Skip to main content
. 2020 Oct 11;35(2):266–275. doi: 10.1177/0269215520962287

Table 2.

Scores on all outcome measures at different time points for intervention and control groups.

Outcome variable Follow-up Intervention group Control group P-value
Mean (95% CI) Mean (95% CI)
ROM* Baseline
2 weeks
6 weeks
12 weeks 95 (83–108) 108 (94–123) 0.180
SIRAS Baseline
2 weeks 12.5 (11.8–13.3) 13.3 (12.6–14.0) 0.155
6 weeks 11.8 (11.0–12.8) 12.8 (12.0–13.7) 0.123
12 weeks
SR adherence for exercise frequency Baseline
2 weeks 94.3 (90.7–98.0) 94.6 (90.8–98.3) 0.933
6 weeks 93.2 (86.9–99.5) 82.9 (76.9–88.8) 0.020
12 weeks
SR adherence for exercise duration Baseline
2 weeks 94.9 (90.6–99.3) 93.3 ± 16 (88.9–97.6) 0.586
6 weeks 93.8 (89.1–98.5) 92.6 (88.2–97.0) 0.721
12 weeks
SR adherence for exercise quality Baseline
2 weeks 86.7 (83.3–90.1) 87.1 (83.8–90.5) 0.866
6 weeks 87.6 (83.4–91.9) 82.5 (78.4–86.7) 0.092
12 weeks
AISEQ Baseline 91.5 (88.8–94.2) 90.5 (87.6–93.7) 0.994
2 weeks 92.8 (90.7–94.9) 92.9 (90.2–95.6) 0.614
6 weeks 91.5 (89.3–93.8) 90.4 (87.4–93.5) 0.600
12 weeks

ROM: range of motion in the proximal interphalangeal and distal interphalangeal joint; SR: self-reported; SIRAS: Sport Injury Rehabilitation Adherence Scale; AISEQ: Athletic Injury Self-Efficacy Questionnaire. Significant difference between the groups is in bold.

*

ROM outcomes assessed only at 12 weeks.